WCO classification path
- Chapter30Pharmaceutical products
- Heading3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified
- Subheading300212Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
- National3002122000Antisera
3002122000
"Antisera"
HS code 3002122000 (Chapter 30 "Pharmaceutical products"; Heading 3002 "Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified"; Subheading 300212 "Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes") under the Korea tariff schedule classifies "Antisera". Korea customs apply MFN rate of 0, WTO bound rate 0. Statutory unit of measure: KG. This commodity is subject to 1 import regulation or restriction; see compliance section below. 31 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 税率 MFN rate | 0 |
WTO 约束税率 WTO bound rate | 0 |
FTA Preferential Rates
31 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AKFTA (ASEAN-Korea) | 0% |
| KAFTA (Korea-Australia) | 0% |
| CKFTA (Canada-Korea) / CPTPP | 0% |
| Korea-Central America (Costa Rica) | 0% |
| Korea-Central America (Honduras) | 0% |
| Korea-Central America (Nicaragua) | 0% |
| Korea-Central America (Panama) | 0% |
| Korea-Central America (El Salvador) | 0% |
| Korea-Chile | 0% |
| Korea-China | 0% |
| Korea-Colombia | 0% |
| Korea-EFTA | 0% |
| Korea-EU | 0% |
| Korea-UK | 0% |
| Korea-Indonesia (CEPA) | 0% |
| Korea-Israel | 0% |
| Korea-India (CEPA) | 0% |
| Korea-Cambodia | 0% |
| Korea-New Zealand | 0% |
| Korea-Peru | 0% |
| Korea-Philippines | 0% |
| RCEP (ASEAN) | 0% |
| RCEP (Australia) | 0% |
| RCEP (China) | 0% |
| RCEP (Japan) | 0% |
| RCEP (New Zealand) | 0% |
| Korea-Singapore | 0% |
| Korea-Turkey | 0% |
| KORUS (Korea-US) | 0% |
| Korea-Vietnam | 0% |
| RCEP | 0% |
Compliance & Controls
1 import regulation, restriction, or permit requirement
화장품법
표준통관예정보고서(화장품)
Global Benchmark
→ China export · Full 13-country compareHS-6 prefix 3002.12 across other jurisdictions